Inhibiting Fatty Acid Synthase to Improve Efficacy of Neoadjuvant Chemotherapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kathy Miller, MD
Professor of Medicine, Ballve' Lantero Scholar
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Georgetown University
Washington D.C., District of Columbia, United States
- Washington Hospital
Washington D.C., District of Columbia, United States
- Indiana University Health North Hospital
Carmel, Indiana, United States
- Indiana University Health Hospital
Indianapolis, Indiana, United States
- Indiana University Health Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
- Spring Mill Medical Center
Indianapolis, Indiana, United States
- Franklin Square Medical Center
Baltimore, Maryland, United States
- Wake Forest Baptist Health
Winston-Salem, North Carolina, United States
- Ohio State University
Columbus, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Nov 2015
- Primary completion
- 21 Nov 2019
- Completion
- 1 Mar 2021
- Last update posted
- 15 Dec 2021
- Registered enrollment
- 42
- Registry id
- NCT02595372
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.